Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tio-Dexiren
- Development stage
- Unknown
- Lead developer
- İlko İlaç
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tio-Dexiren is a fixed-dose combination pharmaceutical product containing dexketoprofen trometamol and thiocolchicoside. Dexketoprofen is a non-steroidal anti-inflammatory drug (NSAID) and the S(+)-enantiomer of ketoprofen, which acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2) to provide analgesic, anti-inflammatory, and antipyretic effects. Thiocolchicoside is a semi-synthetic sulfur derivative of colchicoside that acts as a muscle relaxant with selective affinity for gamma-aminobutyric acid (GABA) and glycine receptors, where it acts as a competitive antagonist. Marketed by Apeks Pharma and manufactured by İlko İlaç, Tio-Dexiren is indicated for the symptomatic treatment of mild to moderate pain associated with musculoskeletal disorders, including muscle spasms, dysmenorrhea, and toothache. The combination is designed to address both the inflammatory pain and the associated muscular tension in musculoskeletal conditions.
- Brand names
- Tio-Dexiren
- Other names
- dexketoprofen + thiocolchicoside
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GABAA (Gamma-aminobutyric acid receptor)Glycine receptor
Beyond the preview
Go deeper on Tio-Dexiren.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tio-Dexiren.